Loading…
the sparker alert will let you know when a significant move starts with an audio alert, so You'll never miss an Opportunity.
Transaction includes upfront and milestone payments totaling up to $2.65 billion.
Edgewise Therapeutics, Inc. (Nasdaq: EWTX) announced the sale of its muscular dystrophy business to Servier. The transaction includes an upfront payment of $1.55 billion and up to $1.1 billion in additional milestone payments, resulting in an aggregate potential sum of up to $2.65 billion.
The sale is expected to significantly impact Edgewise Therapeutics' financial position and strategic focus. The company's free float stands at 78,464,239 shares.
This summary was generated by AI from public sources and may contain errors. Not financial advice. Trade at your own risk.